Pityriasis Rosea Induced by COVID-19 Vaccination

European Journal of Case Reports in Internal Medicine

Eirini Christaki¹  Elina Khattab²  Constantinos Pitsios² 

[1] Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece ;Medical School, University of Cyprus, Nicosia, Cyprus;

关键词: covid-19;    sars-cov-2;    vaccination;    pityriasis rosea;   

DOI  :  10.12890/2022_003164

来源: DOAJ

【 摘 要 】

It is increasingly recognized that SARS-CoV-2 infection and COVID-19 vaccines have been associated with skin disorders, including pityriasis rosea. It has been reported that pityriasis rosea has been triggered by several vaccines, as a rare side-effect. We present two cases of COVID-19 vaccine-induced pityriasis rosea. Skin lesions appeared in a 49-year-old female 8 days after the first dose of the BNT162b2 mRNA vaccine and in a 53-year-old male 7 days after the second dose of the same vaccine. The exanthem was self-limited in both patients over a period of a month.

【 授权许可】

Unknown